446 related articles for article (PubMed ID: 18762907)
41. Metabolic disturbances in non-alcoholic fatty liver disease.
Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
[TBL] [Abstract][Full Text] [Related]
42. Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome.
Gato S; García-Fernández V; Gil-Gómez A; Rojas Á; Montero-Vallejo R; Muñoz-Hernández R; Romero-Gómez M
Eur Cardiol; 2024; 19():e03. PubMed ID: 38807856
[TBL] [Abstract][Full Text] [Related]
43. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.
Ballestri S; Lonardo A; Bonapace S; Byrne CD; Loria P; Targher G
World J Gastroenterol; 2014 Feb; 20(7):1724-45. PubMed ID: 24587651
[TBL] [Abstract][Full Text] [Related]
44. The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population.
Chiang CH; Huang CC; Chan WL; Chen JW; Leu HB
Clin Biochem; 2010 Dec; 43(18):1399-404. PubMed ID: 20846522
[TBL] [Abstract][Full Text] [Related]
45. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question.
Loria P; Lonardo A; Bellentani S; Day CP; Marchesini G; Carulli N
Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):684-98. PubMed ID: 17560098
[TBL] [Abstract][Full Text] [Related]
46. Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction.
Mikolasevic I; Racki S; Lukenda V; Pavletic-Persic M; Milic S; Orlic L
Med Hypotheses; 2014 Jan; 82(1):36-9. PubMed ID: 24280560
[TBL] [Abstract][Full Text] [Related]
47. Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications.
Byrne CD; Targher G
Diabetes Obes Metab; 2022 Feb; 24 Suppl 2():28-43. PubMed ID: 34324263
[TBL] [Abstract][Full Text] [Related]
48. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
[TBL] [Abstract][Full Text] [Related]
49. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
50. Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter.
Chiriac S; Stanciu C; Girleanu I; Cojocariu C; Sfarti C; Singeap AM; Cuciureanu T; Huiban L; Muzica CM; Zenovia S; Nastasa R; Trifan A
Can J Gastroenterol Hepatol; 2021; 2021():6696857. PubMed ID: 33505944
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Pichiri I; Sorgato C; Zenari L; Bonora E
J Hepatol; 2010 Oct; 53(4):713-8. PubMed ID: 20619918
[TBL] [Abstract][Full Text] [Related]
52. The epidemiology, pathogenesis and histopathology of fatty liver disease.
Levene AP; Goldin RD
Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
[TBL] [Abstract][Full Text] [Related]
53. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
[TBL] [Abstract][Full Text] [Related]
54. Epidemiology and natural history of patients with NAFLD.
Bhala N; Younes R; Bugianesi E
Curr Pharm Des; 2013; 19(29):5169-76. PubMed ID: 23394091
[TBL] [Abstract][Full Text] [Related]
55. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
Johnston MP; Patel J; Byrne CD
Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662
[TBL] [Abstract][Full Text] [Related]
56. Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass.
Picardi A; Vespasiani-Gentilucci U
Am J Gastroenterol; 2008 Dec; 103(12):3036-8. PubMed ID: 18853984
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
Targher G; Bertolini L; Padovani R; Rodella S; Tessari R; Zenari L; Day C; Arcaro G
Diabetes Care; 2007 May; 30(5):1212-8. PubMed ID: 17277038
[TBL] [Abstract][Full Text] [Related]
58. Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease.
Vanjiappan S; Hamide A; Ananthakrishnan R; Periyasamy SG; Mehalingam V
Diabetes Metab Syndr; 2018 Jul; 12(4):479-482. PubMed ID: 29402657
[TBL] [Abstract][Full Text] [Related]
59. [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation].
Andreozzi P; Viscogliosi G; Colella F; Subic M; Cipriani E; Marigliano B; Verrusio W; Servello A; Ettorre E; Marigliano V
Recenti Prog Med; 2012 Dec; 103(12):570-4. PubMed ID: 23258240
[TBL] [Abstract][Full Text] [Related]
60. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]